Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Biopharmaceutical Factors Influencing Drug Product Design: Overview01:22

Biopharmaceutical Factors Influencing Drug Product Design: Overview

234
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
234
Bioavailability Enhancement: Drug Solubility Enhancement01:16

Bioavailability Enhancement: Drug Solubility Enhancement

223
Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
223
Factors Influencing Drug Absorption: Pharmaceutical Parameters01:28

Factors Influencing Drug Absorption: Pharmaceutical Parameters

404
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
404
Factors Influencing Drug Absorption: Physicochemical Parameters01:22

Factors Influencing Drug Absorption: Physicochemical Parameters

820
The physicochemical characteristics of drugs play a crucial role in formulating stable and bioavailable drug products. The solubility of a drug, governed by the varying pH along the GI tract and its dissociation constant (pKa), is pivotal in determining its ionization state and absorption rate. Notably, weak acids and bases remain unionized and are absorbed more rapidly.
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
820
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

153
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
153
Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH01:21

Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH

3.1K
Drug absorption within the gastrointestinal (GI) tract is a complex process influenced by several critical factors, including the site pH, the drug's dissociation constant (pKa), and the drug's lipophilicity. The GI tract exhibits a pH gradient, with an acidic environment in the stomach and a more alkaline environment in the small intestine. This pH variation directly affects the ionization state of drugs.
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
3.1K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Correlation of Molecular State and Drug Release in Irinotecan-Loaded Liposomes Using Different Trapping Agents.

Molecular pharmaceutics·2026
Same author

Effect of formulation components on surface free energy of orodispersible films.

Drug development and industrial pharmacy·2026
Same author

Assessment of crystalline carbamazepine in bilayer tablets by transmission low-frequency Raman spectroscopy.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2026
Same author

Relationship between Phase Transition and Drug Release of Doxorubicin-Encapsulated Liposomes with Different Lipid Compositions Using Raman Spectroscopy.

Biological & pharmaceutical bulletin·2025
Same author

Evaluation of the Film-Forming Ability for Heparinoid Cream Formulations.

Chemical & pharmaceutical bulletin·2025
Same author

Quantification of drug contents in molded tablets <i>via</i> transmission low-frequency Raman spectroscopy.

The Analyst·2025

相关实验视频

Updated: Jan 17, 2026

Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid
05:08

Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid

Published on: September 20, 2017

17.7K

使用物理化学性质的溶解制剂技术的合理选择.

Kouya Kimoto1, Katsuhiko Yamamoto2,3, Toshiro Fukami4

  • 1Analytical Development, Pharmaceutical Sciences, Takeda Pharmaceutical Company Limited, 2-26-1 Muraoka-Higashi, Fujisawa, Kanagawa 251-8555, Japan.

Chemical & pharmaceutical bulletin
|September 18, 2025
PubMed
概括

选择药物配方技术,如无形固体分散 (ASD),基于脂质的配方 (LBF) 和纳米晶体 (NC),可以根据分子性质进行指导. 本研究确定了优化早期药物开发和加速时间表的关键指标.

关键词:
无形固体分散的无形固体分散循环德克斯特林 (Cyclodextrin) 是一种循环德克斯特林.这是一种基于脂质的配方.纳米晶体纳米晶体是什么物理化学属性 物理化学属性溶解度 溶解度 溶解度 溶解度

更多相关视频

Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs
08:18

Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs

Published on: July 27, 2022

1.5K
Author Spotlight: Accelerating Discovery in Microporous Material Chemistry
07:20

Author Spotlight: Accelerating Discovery in Microporous Material Chemistry

Published on: October 6, 2023

4.3K

相关实验视频

Last Updated: Jan 17, 2026

Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid
05:08

Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid

Published on: September 20, 2017

17.7K
Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs
08:18

Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs

Published on: July 27, 2022

1.5K
Author Spotlight: Accelerating Discovery in Microporous Material Chemistry
07:20

Author Spotlight: Accelerating Discovery in Microporous Material Chemistry

Published on: October 6, 2023

4.3K

科学领域:

  • 制药科学 制药科学
  • 药物运输 药物运输 药物运输
  • 制定 发展 制定 发展

背景情况:

  • 改善水溶性较差的药物的溶性对于口服小分子药物开发至关重要.
  • 缺乏客观指标阻碍了选择合适的溶化制剂技术.
  • 配方技术的早期选择会影响开发时间表.

研究的目的:

  • 为无形固体分散 (ASD),循环素 (CD),基于脂质的配方 (LBF) 和纳米晶体 (NC) 技术建立选择指标.
  • 为了利用分子特性来指导配方技术的选择.
  • 通过提供合理的选择标准,加速药物开发的早期阶段.

主要方法:

  • 在市场上销售的口服药物的分子特性 (分子量,点 (Tm),Log P,极地表面积 (PSA)) 的分析.
  • 使用单属性和多属性地块进行数据可视化.
  • 开发一个组合的属性图 (Tm和规范的Log P/PSA) 来确定最佳的配方范围.

主要成果:

  • 单属性地块显示了分子性质的频率分布.
  • 一个多个属性的地块确定了ASD,LBF和NC技术的最佳选择范围.
  • 根据分析的分子性质,发现循环德克斯 (CD) 技术在确定最佳范围之外.

结论:

  • 分子性质分析为选择溶化配方技术提供了客观指标.
  • 开发的指标可以指导ASD,LBF和NC在药物开发早期阶段的合理选择.
  • 这种方法通过利用早期分子数据来促进加速开发时间表.